John James bought Novo Nordisk A/S (NYSE: NVO)
John James (R-MI), a U.S. Representative, has disclosed 2 trades in Novo Nordisk A/S (NVO) since 2023, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: John James bought $1,001 - $15,000 of Novo Nordisk A/S (NYSE: NVO) on November 10, 2023. Since that trade, NVO is down -45.07% against the S&P 500 up +73.67%, an outperformance of -118.74%.
Across these filings, John James has been a balanced trader of NVO (a buy-to-sell ratio of 1.00). The most recent disclosed NVO transaction shown was dated September 4, 2024. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
John James's NVO trades vs the price
NVO is down -45.07% since John James bought on November 10, 2023, versus +73.67% for the S&P 500.
Performance since this trade
All John James NVO trades
John James & NVO trading FAQ
Is it legal for John James to trade Novo Nordisk A/S (NVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novo Nordisk A/S (NVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John James buy NVO?
John James disclosed a purchase of $1,001 - $15,000 of Novo Nordisk A/S (NVO) on November 10, 2023, according to public STOCK Act filings.
How has NVO performed since John James's trade?
Since John James bought NVO on November 10, 2023, the stock is down -45.07%, versus +73.67% for the S&P 500 over the same period, an outperformance of -118.74%.
How many times has John James traded NVO?
John James has disclosed 2 NVO trades since 2023 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVO trades?
Quantellect tracks every disclosed congressional trade in Novo Nordisk A/S (NVO) on the Novo Nordisk A/S congressional trading page, which aggregates filings across all members of Congress.
John James's NVO tradesAll congressional filings for Novo Nordisk A/SJohn James's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.